Docteur IHenry endocrinologie-diabétologie
0549.782.241 · rovalta.com · 28/09/2026
Docteur IHenry endocrinologie-diabétologie
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODocteur IHenry endocrinologie-diabétologie is a Private limited company incorporated in 2014. Its registered office is in Ham-sur-Heure-Nalinnes.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0549.782.241
- Incorporation
- 28/03/2014
- Legal form
- Private limited company
- Registered office
- Rue Praile(NAL) 71
6120 Ham-sur-Heure-Nalinnes · WallonieSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 12 filingsTrend over 10 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 167,5 k € | +28.2% | 130,7 k € | +2594% | 4,9 k € | -90.8% | 52,7 k € | +144% | 21,6 k € |
| EBITDA | 166,9 k € | +29.9% | 128,5 k € | +2704% | 4,6 k € | -91.2% | 51,9 k € | +147% | 21 k € |
| Operating result | 165,4 k € | +29.6% | 127,6 k € | +3572% | 3,5 k € | -93.2% | 51,2 k € | +157% | 19,9 k € |
| Net result | 107,8 k € | +23.5% | 87,3 k € | +11441% | 756,5 € | -97.8% | 35,2 k € | +175% | 12,8 k € |
| Balance sheet | |||||||||
| Equity | 220,5 k € | +41.7% | 155,5 k € | -2.9% | 160,3 k € | +0.5% | 159,5 k € | +28.3% | 124,3 k € |
| Total assets | 318,1 k € | +13.4% | 280,5 k € | +68.1% | 166,9 k € | -3.9% | 173,7 k € | +31.5% | 132,1 k € |
| Cash | 124 k € | +97.6% | 62,8 k € | +269% | 17 k € | -70.7% | 58,1 k € | +11.6% | 52 k € |
| Debts | 97,6 k € | -21.9% | 125 k € | +1793% | 6,6 k € | -53.4% | 14,2 k € | +82.1% | 7,8 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Isabelle HENRY | Administrator - managersince 28/03/2014Director18/02/2014 → 2024 accountsendedMandate2017 accountsendedManager2018 accountsended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 24/07/2026 | 14/07/2025 | 16/07/2024 | 03/07/2023 | 04/07/2022 | 07/07/2021 |
| General meeting | 15/06/2026 | 30/06/2025 | 15/06/2024 | 15/06/2023 | 15/06/2022 | 17/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 15/06/2026 | 24/07/2026 | French | |
| Micro model | 31/12/2024 | 30/06/2025 | 14/07/2025 | French | |
| Micro model | 31/12/2023 | 15/06/2024 | 16/07/2024 | French | |
| Micro model | 31/12/2022 | 15/06/2023 | 03/07/2023 | French | |
| Micro model | 31/12/2021 | 15/06/2022 | 04/07/2022 | French | |
| Micro model | 31/12/2020 | 17/06/2021 | 07/07/2021 | French | |
| Micro model | 31/12/2019 | 15/06/2020 | 01/07/2020 | French | |
| Micro model | 31/12/2018 | 17/06/2019 | 27/06/2019 | French | |
| Micro model | 31/12/2017 | 25/06/2018 | 02/07/2018 | French | |
| Micro model | 31/12/2016 | 15/06/2017 | 15/06/2017 | French | |
| Abridged model | 31/12/2015 | 15/06/2016 | 23/06/2016 | French | |
| Abridged model | 31/12/2014 | 25/06/2015 | 09/07/2015 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Isabelle HENRY | Administrator - managersince 28/03/2014Director18/02/2014 → 2024 accountsendedMandate2017 accountsendedManager2018 accountsended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Registered office01/04/2026SIEGE SOCIAL
- Mandates16/06/2021STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
- Registered office13/05/2015SIEGE SOCIAL
- Other01/04/2014RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Rue Praile(NAL) 71, 6120 Ham-sur-Heure-NalinnesCurrent | accounts 2025 | Accounts 2025 · 2026-00344128 |
| Rue Des Victoria Cross 1 Bte32, 7030 Saint-Symphorien | accounts 2021 → 2024 | Accounts 2024 · 2025-00263025 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Docteur IHenry endocrinologie-diabétologieCurrent | accounts 2025 | Accounts 2025 · 2026-00344128 |
| Dr I. HENRY - ENDO-DIABETOLOGIE | accounts 2021 → 2024 | Accounts 2024 · 2025-00263025 |
| Docteur IHenry endocrinologie-diabétologie | accounts 2014 → 2020 | Accounts 2020 · 2021-32200038 |
Events
- 2025Annual accounts 2025107,8 k €↑
- 2025Name changeDocteur IHenry endocrinologie-diabétologie
- 2024Annual accounts 202487,3 k €↑
- 2023Annual accounts 2023756,5 €↓
- 2022Annual accounts 202235,2 k €↑
- 2021Annual accounts 202112,8 k €↓
- 2021Name changeDr I. HENRY - ENDO-DIABETOLOGIE
- 2018Annual accounts 201833,6 k €↑
- 2017Annual accounts 201718,6 k €↓
- 2016Annual accounts 201629,1 k €↑
- 2015Annual accounts 201528,2 k €↓
- 2014Annual accounts 201430,2 k €
- 28/03/2014IncorporationPrivate limited company